black chokeberry extract_lipo apigenin

This event is a perfect occasion for us to connect, exchange ideas, and explore collaborative possibilities. Whether you’re an existing partner or a prospective client, we value the chance to engage with you and showcase what we’ve been working on.

Led by Shuba Singhal, PhD, this randomized, controlled clinical study was conducted at the Department of Orthopedics of Lok Nayak Jai Prakash Hospital/Maulana Azad Medical College, New Delhi. For the study, 193 patients diagnosed with osteoarthritis of the knee were randomized to receive either turmeric extract (BCM-95) as a 500 mg capsule two times daily, or a 650 mg tablet of paracetamol three times daily for six weeks.

“This study re-affirms the anti-arthritic effect of BCM-95 and provides renewed hope for millions to improve their quality of life,” said Nipen Lavingia, brand innovation advisor for Arjuna Natural based in Dallas, TX.

Vitafoods Europe is the most influential exhibition of nutritional health products and functional foods in Europe. The global nutraceutical supply chain comes together to provide a perfect platform for creating new business and establishing profitable relationships, and is the only professional covering four key areas from raw materials and raw materials, branded finished products, OEM and private label, service and equipment Activity. Various conference events are held during Vitafoods Europe in Geneva, Switzerland, providing visitors with an opportunity to learn new things and network. is where nutrition experts create innovations, shape the future of the industry, find effective solutions to future problems, and connect with business leaders. With the vigorous development of nutraceuticals and food, Vitafoods Europe, Geneva Health Food and Raw Materials Exhibition, has gone through years of market testing and has taken the leading position in emerging markets.

Knee arthritis symptoms of pain, joint stiffness, and diminished physical function were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). After six weeks of treatment, responder analysis showed significant improvement in WOMAC scores across all parameters comparable to the paracetamol group, with 18% of the BCM-95 group reporting 50% improvement, and 3% of subjects noting 70% improvement.